DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ — Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, C&TECH, and BeringLab are chosen for the support program.

This initiative selects innovative technology companies in the fields of machinery, energy, AI/IoT and bio health. The program provides comprehensive consulting support to help these companies apply their technologies and products on a trial basis to local facilities or projects operated by overseas companies and institutions, enabling on-site commercialization.

1. C&TECH – Smart IoT Asset Management System

The first company, C&TECH, its Smart IoT Asset Management System enables real-time monitoring and analysis of physical and operational assets — including machinery, equipment, and facility infrastructure.
The system integrates proprietary IoT devices with AI analytics to collect and interpret data on asset location, utilization, and operational patterns, helping organizations improve efficiency and manage assets more intelligently.

Built on a multi-sensor port architecture, each IoT device can connect additional sensor modules to collect different types of environmental and operational data depending on the application.
C&TECH has established its business in the financial products domain, providing asset monitoring solutions for corporate secured lending.
Now, by leveraging its multi-sensor functionality, the company is commercializing applications in facility and building management, expanding the use of its platform across different operational environments.

Key Features

• Real-time monitoring through GPS- and cellular-enabled IoT devices
• AI-based monitoring for productivity anomalies
• Multi-sensor port architecture enabling data expansion
• Cloud-based dashboard for centralized management

With proven experience in secured lending and industrial IoT fields, C&TECH continues to expand its technology globally through North American commercialization programs.

Inquiries: info@cntech.pro 
Website: https://iot-cntech.com 

2. BeringLab – AI Powered Legal and Patent Translation

The second company, Bering Lab, a leader in AI-powered legal and patent translation, provides domain-specific AI translation and post-editing solutions for legal, patent, and other highly regulated industries. The company serves over 240 enterprise clients worldwide.

It has announced its acquisition of Intersphere, one of Korea’s most established translation providers. The deal marks a key step in Bering Lab’s plan to build the first AI-driven roll-up platform in the language-services industry.

The acquisition combines Bering Lab’s proprietary AI translation technology with Intersphere’s 20-year service legacy and deep client relationships across sectors including life sciences, manufacturing, and gaming. Intersphere will continue operating under its own brand while progressively integrating Bering Lab’s AI tools to enhance speed, accuracy, and scalability.

“This acquisition is more than expansion – it’s the foundation of a broader AI roll-up strategy,” said Jae Yoon Kim, Co-CEO of Bering Lab. “By combining our AI technology with Intersphere’s long-standing commitment to customer service, we’re building a platform that delivers both innovation and reliability. Clients will benefit from faster, more consistent results without sacrificing the personalized support they value.”

The deal follows Bering Lab’s earlier acquisition of Tombali, Korea’s second-largest legal translation provider, reinforcing its position as the first company in the industry to execute an AI-based consolidation strategy.

Inquiries: sales@beringlab.com
Website: https://beringlab.com/

If you have any questions about these three energy sector items, please feel free to contact us at the information below:

Email : bsr@bsrkorea.com

First cyclotron outside Klang Valley to anchor Malaysia’s advanced cancer care ecosystem

KEY-HIGHLIGTHS

• RM500 million investment in advanced cancer care infrastructure
• State-of-the-art diagnostic and treatment facilities, including a nuclear medicine centre
• First cyclotron outside the Klang Valley enabling local radioisotope production for cancer detection and therapy
• Located in Larkin Sentral within the Johor–Singapore Special Economic Zone (JS-SEZ)
• Phase One projected to create around 1,000 direct and indirect jobs

JOHOR BAHRU, Malaysia and SINGAPORE, Nov. 26, 2025 /PRNewswire/ — Singapore-based healthcare provider Precious Medical Group today announced the launch of the Tunku Laksamana Johor Cancer Centre and Hospital, a landmark RM500 million development featuring state-of-the-art diagnostic and treatment facilities. The project aims to elevate oncology capacity in and beyond Johor while strengthening collaboration across Malaysia’s public and private healthcare systems.

The first phase of the project, the Tunku Laksamana Johor Cancer Centre, will be inaugurated on 5th December 2025. It will feature advanced diagnostic and treatment capabilities, including a PET-CT and radiotherapy centre. When fully completed, it will also house a nuclear medicine facility equipped with Malaysia’s first cyclotron outside the Klang Valley, enabling on-site production of medical radioisotopes for cancer imaging and therapy. This development will enhance early detection, improve treatment availability, and reduce dependence on distant radioisotope supply chains.

Construction and operations are projected to generate around 1,000 direct and indirect jobs, contributing to workforce development and supporting the broader goals of the Johor–Singapore Special Economic Zone (JS-SEZ) to drive high-value healthcare services. Following the centre’s launch, Precious Medical Group will proceed with the development of a 200-bed hospital on the same site to provide comprehensive inpatient oncology and integrated support services.

Strategically located at Larkin Sentral, a major transport hub within the JS-SEZ, the project is positioned to facilitate cross-border medical collaboration, talent mobility, and knowledge transfer—further strengthening the resilience, capacity, and international reputation of Malaysia’s healthcare system, which already attracts more than 1.5 million medical tourists annually.

The hospital is named after the late Tunku Abdul Jalil, the fourth child of His Majesty Sultan Ibrahim of Johor and Her Majesty Raja Zarith Sofiah, who passed away at the age of 25 after bravely battling liver cancer. The centre was conceived to fulfil his wish of alleviating the suffering of cancer patients.

“This hospital is a tribute to the memory of Tunku Abdul Jalil, whose courage, strength, and resilience in the face of adversity remain an inspiration to all,” said Dr William Chong, Founder and Managing Director of Precious Medical Group. “Tunku Jalil’s modest, kind, and compassionate nature embodies the philosophy of this hospital — the spirit of caring and sharing.”

With the upcoming RTS Link set to enhance cross-border mobility, the Tunku Laksamana Johor Cancer Centre and Hospital will strengthen Johor’s role as a gateway for advanced collaboration between Malaysia and Singapore. The project reflects the building of a seamless ecosystem for medical treatment, training, and innovation, serving patients across both nations and the wider region. It stands as a symbol of regional partnership, economic growth, and human progress, positioning Johor as a new focal point for high-value healthcare within ASEAN.

About Precious Medical Group

Precious Medical Group is a leading healthcare provider in Singapore, operating a 14,000 sq ft flagship medical centre at Paragon Medical Tower, offering specialist services, health screening, dentistry, day surgery, and advanced imaging (CT, mammography, and MRI). The Group also operates two nursing homes with 496 licensed beds and nine Active Ageing Centres serving over 6,000 seniors across Singapore. Founded by Dr William Chong, a senior dental surgeon, Precious Medical Group reflects his belief in patient centric, multi-disciplinary care. His lifelong passion for healthcare innovation, and compassion for the underprivileged has driven him to work towards finding solutions to underlying issues, in particular those affecting the elderly, and for patients with cancer. The Tunku Laksamana Johor Cancer Centre and Hospital marks the group’s first venture in Malaysia and is owned and operated by its related company Precious Hospital Sdn. Bhd.

Sherrena Koh
Contact:  +60 19 589 3077  |   Email: sherrena@tljcancercentre.com

BEIJING, Nov. 26, 2025 /PRNewswire/ — A report from 1dai1lu.cn.

“The waves are rising on deeper waters.”

In 2025, global business is entering a singular moment for leaders of Chinese heritage — a shift from isolated individual achievements to a systemic presence across multinational corporations, international organizations, and institutions that shape global rules. Their influence increasingly transcends wealth and innovation, extending into governance, standard-setting, and cultural interpretation.

Standing at the intersection of these rising tides is Dr. Joe (Yizhou) He, Managing Director and CEO China of Australian Capital Equity, who has emerged as a distinctive bridge between global investors and the world’s most complex, dynamic emerging markets.

From institutional allocators to family offices to corporate leaders, Dr. He occupies an unusual and valuable position: someone fluent in the operating logic of China, the expectations of Western capital, and the practical pathways that connect the two.

“International capital doesn’t just need access — it needs structure, clarity, and someone who can translate complexity into opportunity.”

The Architecture of Understanding: A Career Forged Across Systems

Dr. He’s global perspective runs deeper than resume lines. After completing his master’s degree at the University of Cambridge, he began his career in a global investment bank, drawn less to titles than to complexity. “Global markets reward those who understand the logic behind the logic.” he recalls.

His early years at Fosun Group put him on the front lines of cross-border investment. In his twenties, he took part in the acquisition in the Middle East — working in 50-degree heat, navigating cultural barriers, and managing geopolitical uncertainty. It was a formative experience.

“A deal doesn’t succeed because numbers align—it succeeds because interests align.”

It taught him that global investment is not merely financial—it is anthropological, psychological, and deeply structural.

Investment Philosophy and Global Trends: Reading the World Through Structure

Dr. He’s investment worldview — shaped by experience across Asia, the U.S., the Middle East, Europe, and Australia — is grounded in a single conviction: long-term value emerges from structure, not sentiment. His approach seamlessly connects investment principles with a clear-eyed reading of global shifts.

He focuses on three enduring foundations that guide how he interprets both companies and entire economies:

1. Productivity as the North Star

Whether AI, blockchain, or digital infrastructure, he looks for technologies that permanently raise human productivity.

“Productivity is the only compounding force that never reverses.”

2. Structure Over Sentiment

He cautions global investors against the emotional narratives that drive short-term market cycles.

“Sentiment follows structure. If you understand regulation, industry formation, and cost curves, you will outperform narratives.”

3. Value Creation Before Capital Extraction

Across emerging markets, he believes global capital performs best when it creates durable industrial value rather than pursuing quick arbitrage.

“International investors who create real industrial value always outperform those looking for arbitrage.”

Building on these principles, Dr. He applies a framework for interpreting global trends that avoids ideological lenses and focuses instead on structural inevitabilities:

• AI and Blockchain as Twin Transformations

AI as the next engine of enterprise productivity; blockchain as the architecture for future trust and cross-border transaction systems.

• Parallel Innovation Systems

He sees not a world converging toward one technological model, but multiple innovation systems — Silicon Valley, East Asia, the Middle East — evolving in parallel, sometimes competitive, often complementary.

“The next decade will not be defined by convergence, but by coexistence.”

• Capital Corridors Across Regions

With experience spanning Australia, China, the Middle East, and the U.S., he has witnessed new financial corridors forming — especially around supply-chain security, energy transition, and sovereign investment.

• Asia-Pacific as the Next Structural Center of Gravity

He believes APAC will become the world’s most dynamic region for cross-border capital, not because of short-term cycles but due to demographic scale, technology supply chains, and structural demand.

The Quiet Power of Curiosity: Stories Behind the Strategy

What distinguishes Dr. He in the global investment community is not only his technical clarity but also the way he approaches people and organizations.

Middle Eastern Heat, A Young Negotiator, and a Lesson in Humility

During the acquisition in the Middle East, local partners were initially skeptical of the young negotiator across the table. Instead of confronting doubt, Dr. He relied on preparation, cultural sensitivity, and quiet confidence. Trust was built not by force, but by clarity.

Many years later, he still recalls the smell of the desert air at night, the silence of the foreign office buildings, and the moment he realized he was becoming “a global operator, not just a deal-maker.”

A Question That Reveals Culture

In his early days at Australian Capital Equity, he asked a group of senior executives:

“What made you stay here for 20 or 30 years?”

The answers — consistency, integrity, purpose — convinced him that longevity in business is not luck but culture.

“That question told me more about the company than any financial statement.” he says.

Building Pathways, Not Just Portfolios

At Australian Capital Equity, Dr. He now focuses on helping global capital deploy into China and Asia in ways that are deliberate, structured, and aligned with long-term opportunity. He rejects binary thinking and instead emphasizes clarity, risk design, and sustainable value creation.

“Capital moves where there is trust. Trust grows where there is understanding.”

His work centers on building that understanding — between China and multinational headquarters, between emerging technologies and global investors, and between regions whose futures are becoming increasingly interdependent.

A Leader for the Next Investment Epoch

In a world defined by uncertainty, Dr. Joe (Yizhou) He offers something rare: a viewpoint that is both analytical and human, ambitious yet grounded, young yet mature.

For global investors seeking to interpret Asia’s next cycle — and to participate in it with confidence — he stands as one of the most compelling voices of his generation.

“The future belongs to those who can translate complexity into clarity — and clarity into action.”